http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100454647-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-587 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-74 |
| filingDate | 2001-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100454647-B1 |
| titleOfInvention | Dialkylhydroxybenzoic Acid Derivatives Containing Metal Chelating Groups and Their Therapeutic Uses |
| abstract | The present invention relates to novel dialkylhydroxybenzoic acid derivatives containing metal complex groups and various medical dysfunctions and diseases caused by excess of reactive oxygen species (ROS) and / or zinc ions, in particular strokes. and strokes, Parkinson's disease and Alzheimer's disease for their use for the treatment and / or prophylaxis. The compounds of the present invention not only have low toxicity, but also have similar or better lipid peroxidation (LPO) inhibitory activity than the comparative compounds. The compounds effectively inhibit cerebral neuronal cell death by free radicals (ROS) and / or excess zinc and exhibit a neuroprotective effect on ischemic neurodegeneration. |
| priorityDate | 2001-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 696.